Someone wants them and at 3 cents could be a good deal. ~$30million MD post dilution is cheap for a bio for the products they got if they realise some potential. With this and the line of credit should put them in good stead for commercialisation.
- Forums
- ASX - By Stock
- NAL
- rights issue
rights issue, page-6
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)